Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction.
Bladder outlet obstruction
Lower urethral tract symptom
Metastatic prostate cancer
Prostate biopsy
Thulium laser resection of the prostate
Journal
Lasers in medical science
ISSN: 1435-604X
Titre abrégé: Lasers Med Sci
Pays: England
ID NLM: 8611515
Informations de publication
Date de publication:
18 Aug 2023
18 Aug 2023
Historique:
received:
06
04
2023
accepted:
03
08
2023
medline:
21
8
2023
pubmed:
19
8
2023
entrez:
18
8
2023
Statut:
epublish
Résumé
Metastatic prostate cancer (mPCa) patients complicated with bladder outlet obstruction (BOO) are often referred to a urologist. Androgen deprivation therapy (ADT) combined with indwelling catheter usually be the initial management. To retrospectively analysis the safety and efficacy of simultaneous thulium laser resection of the prostate (TmLRP) and transperineal prostate biopsy in metastatic prostate cancer with bladder outlet obstruction. From January 2016 to December 2021, 67 clinically diagnosed mPCa with BOO patients were included in this study. All patients were preoperatively assessed with international prostate symptom score (IPSS), QoL, serum prostate-specific antigen (PSA), prostate volume evaluation by transrectal ultrasound, postvoid residual urine volume (PVR), and maximum flow rate (Q
Identifiants
pubmed: 37596454
doi: 10.1007/s10103-023-03848-5
pii: 10.1007/s10103-023-03848-5
doi:
Substances chimiques
Thulium
8RKC5ATI4P
Androgen Antagonists
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
188Subventions
Organisme : National Natural Science Foundation of China
ID : 81872098
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.
Références
Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A (2020) Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol 77(1):38–52. https://doi.org/10.1016/j.eururo.2019.08.005
doi: 10.1016/j.eururo.2019.08.005
pubmed: 31493960
Liu X, Yu C, Bi Y, Zhang ZJ (2019) Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China. Public Health 172:70–80. https://doi.org/10.1016/j.puhe.2019.04.016
doi: 10.1016/j.puhe.2019.04.016
pubmed: 31220754
Ma CG, Ye DW, Li CL et al (2008) Epidemiology of prostate cancer from three centers and analysis of the first-fine hormonal therapy for the advanced disease[in Chinese]. Chin J Surg 46(12):921–925. https://doi.org/10.3321/j.issn:0529-5815.2008.12.012
doi: 10.3321/j.issn:0529-5815.2008.12.012
pubmed: 19035151
Teo MY, Rathkopf DE, Kantoff P (2019) Treatment of advanced prostate cancer. Annu Rev Med 70:479–499. https://doi.org/10.1146/annurev-med-051517-011947
doi: 10.1146/annurev-med-051517-011947
pubmed: 30691365
pmcid: 6441973
Lee F, Torp-Pedersen ST, Siders DB (1989) The role of transrectal ultrasound in the early detection of prostate cancer. CA Cancer J Clin 39(6):337–360
doi: 10.3322/canjclin.39.6.337
pubmed: 2482116
Hamilton W, Sharp DJ, Peters TJ, Round AP (2006) Clinical features of prostate cancer before diagnosis: a population-based, case-control study. Br J Gen Pract 56(531):756–762
pubmed: 17007705
pmcid: 1920715
Hamilton W, Sharp D (2004) Symptomatic diagnosis of prostate cancer in primary care: a structured review. Br J Gen Pract 54(505):617–621
pubmed: 15296564
pmcid: 1324845
Ok JH, Meyers FJ, Evans CP (2005) Medical and surgical palliative care of patients with urological malignancies. J Urol 174(4 Pt 1):1177–1182. https://doi.org/10.1097/01.ju.0000173077.84274.01
doi: 10.1097/01.ju.0000173077.84274.01
pubmed: 16145365
Xia S-J, Zhuo J, Sun X-W, Han B-M, Shao Y, Zhang Y-N (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389. https://doi.org/10.1016/j.eururo.2007.05.019
doi: 10.1016/j.eururo.2007.05.019
pubmed: 17566639
Schaeffer E, Srinivas S, Antonarakis ES et al (2021) NCCN guidelines insights: prostate cancer, version 1.2021. J Natl Compr Canc Netw 19(2):134–143. https://doi.org/10.6004/jnccn.2021.0008
doi: 10.6004/jnccn.2021.0008
pubmed: 33545689
Cornford P, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol 79(2):263–282. https://doi.org/10.1016/j.eururo.2020.09.046
doi: 10.1016/j.eururo.2020.09.046
pubmed: 33039206
Lehrer S, Stone NN, Droller MJ, Stock RG (2002) Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer. Urol Oncol 7(2):73–76. https://doi.org/10.1016/s1078-1439(01)00155-7
doi: 10.1016/s1078-1439(01)00155-7
pubmed: 12474526
Rom M, Waldert M, Schatzl G, Swietek N, Shariat SF, Klatte T (2014) Bladder outlet obstruction (BOO) in men with castration-resistant prostate cancer. BJU Int 114(1):62–66. https://doi.org/10.1111/bju.12438
doi: 10.1111/bju.12438
pubmed: 24053594
Franiel T, Lüdemann L, Rudolph B et al (2009) Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters. Radiology 252(1):101–108. https://doi.org/10.1148/radiol.2521081400
doi: 10.1148/radiol.2521081400
pubmed: 19561252
Rieken M, Bachmann A (2014) Laser treatment of benign prostate enlargement–which laser for which prostate? Nat Rev Urol 11(3):142–152. https://doi.org/10.1038/nrurol.2014.23
doi: 10.1038/nrurol.2014.23
pubmed: 24595121
Tanaka M, Suzuki N, Nakatsu H, Murakami S, Matsuzaki O, Shimazaki J (2003) Significance of capsular attachment and invasion of cancer tissues in prostate cancer. Int J Urol 10(6):309–314
doi: 10.1046/j.1442-2042.2003.00630.x
pubmed: 12757602
Mottet N, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79(2):243–262. https://doi.org/10.1016/j.eururo.2020.09.042
doi: 10.1016/j.eururo.2020.09.042
pubmed: 33172724
Shankar PR, Ellimoottil C, George AK et al (2021) Testing-related health impact of transrectal and transperineal prostate biopsy as assessed by health utilities. J Urol 206(6):1403–1410. https://doi.org/10.1097/JU.0000000000002118
doi: 10.1097/JU.0000000000002118
pubmed: 34288719
Chang DTS, Challacombe B, Lawrentschuk N (2013) Transperineal biopsy of the prostate–is this the future? Nat Rev Urol 10(12):690–702. https://doi.org/10.1038/nrurol.2013.195
doi: 10.1038/nrurol.2013.195
pubmed: 24061531
Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64(6):876–892. https://doi.org/10.1016/j.eururo.2013.05.049
doi: 10.1016/j.eururo.2013.05.049
pubmed: 23787356
Ploussard G, Dubosq F, Boublil V et al (2009) Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen. J Urol 182(4):1342–1349. https://doi.org/10.1016/j.juro.2009.06.050
doi: 10.1016/j.juro.2009.06.050
pubmed: 19683310
Lin C-C, Huang WJS, Wu L-J, Chang Y-H, Lin ATL, Chen K-K (2008) Diagnosis of prostate cancer: repeated transrectal prostate biopsy or transurethral resection. J Chin Med Assoc 71(9):448–454. https://doi.org/10.1016/S1726-4901(08)70147-3
doi: 10.1016/S1726-4901(08)70147-3
pubmed: 18818137
Fang K, Song P, Zhang J et al (2021) The impact of palliative transurethral resection of the prostate on the prognosis of patients with bladder outlet obstruction and metastatic prostate cancer: a population-matched study. Front Surg 8:726534. https://doi.org/10.3389/fsurg.2021.726534
doi: 10.3389/fsurg.2021.726534
pubmed: 34778357
pmcid: 8586220
Choi SY, Ryu J, You D et al (2018) Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching study. J Cancer Res Clin Oncol 144(4):751–758. https://doi.org/10.1007/s00432-018-2597-5
doi: 10.1007/s00432-018-2597-5
pubmed: 29417257
Qu M, Zhu F, Chen H et al (2019) Palliative transurethral resection of the prostate in patients with metastatic prostate cancer: a prospective study of 188 patients. J Endourol 33(7):570–575. https://doi.org/10.1089/end.2019.0108
doi: 10.1089/end.2019.0108
pubmed: 31025578
Heung YM, Walsh K, Sriprasad S, Mulvin D, Sherwood RA (2000) The detection of prostate cells by the reverse transcription-polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate. BJU Int 85(1):65–69. https://doi.org/10.1046/j.1464-410x.2000.00380.x
doi: 10.1046/j.1464-410x.2000.00380.x
pubmed: 10619948
Moreno JG, O’Hara SM, Long JP et al (1997) Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. Urology 49(4):515–520. https://doi.org/10.1016/s0090-4295(97)00016-2
doi: 10.1016/s0090-4295(97)00016-2
pubmed: 9111619